Clinical Trial

Multicenter Registry of Patients With Subarachnoid Hemorrhage

Study acronym: MEASURE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 19, 2026 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.
Trial Details
NCT Number NCT07482124
Lead Sponsor UMC Utrecht
Collaborators: Dutch Heart Foundation, The Dutch Brain Foundation, Radboud University Medical Center, Erasmus Medical Center, Maastricht University Medical Center, Elisabeth-TweeSteden Ziekenhuis, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Isala, Medical Center Haaglanden, University Medical Center Groningen
Conditions Subarachnoid Hemorrhage, Spontaneous
Enrollment 1,000 participants
Start Date 2024-02-12
Primary Completion 2026-08-01 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-19